Mechanisms of cytochrome c release by proapoptotic BCL-2 family members
被引:655
作者:
Scorrano, L
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USAHarvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA
Scorrano, L
[1
]
Korsmeyer, SJ
论文数: 0引用数: 0
h-index: 0
机构:
Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USAHarvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA
Korsmeyer, SJ
[1
]
机构:
[1] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA
A crucial amplificatory event in several apoptotic cascades is the nearly complete release of cytochrome c from mitochondria. Proteins of the BCL-2 family which include both anti- and proapoptotic members control this step. Here, we review the proposed mechanisms by which proapoptotic BCL-2 family members induce cytochrome c release. Data support a model in which the apoptotic pathway bifurcates following activation of a "BH3 only" family member. BH3 only molecules induce the activation of the multidomain proapoptotics BAX and BAK, resulting in the permeabilization of the outer mitochondrial membrane and the efflux of cytochrome c. This is coordinated with the activation of a distinct pathway characterized by profound changes of the inner mitochondrial membrane morphology and organization. This mitochondrial remodelling insures complete release of cytochrome e and the onset of mitochondrial dysfunction that is a typical feature of many apoptotic deaths. (C) 2003 Elsevier Science (USA). All rights reserved.
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Antonsson, B
Montessuit, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Montessuit, S
Lauper, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Lauper, S
Eskes, R
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Eskes, R
Martinou, JC
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Antonsson, B
Montessuit, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Montessuit, S
Lauper, S
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Lauper, S
Eskes, R
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland
Eskes, R
Martinou, JC
论文数: 0引用数: 0
h-index: 0
机构:
Ares Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, SwitzerlandAres Serono Int SA, Serono Pharmaceut Res Inst, CH-1228 Geneva, Switzerland